CMSS Board of Directors
Sue Sedory, MA, CAE
Susan (Sue) Sedory, M.A., CAE, is a respected chief executive with more than 30 years of experience working in association, corporate and federal government sectors.
Currently, Ms. Sedory (formerly Sedory Holzer) is the Executive Director of the American College of Emergency Physicians (ACEP), the national medical society representing emergency medicine. As Executive Director, she oversees ACEP’s $42M annual operations and works on behalf of its 40,000 emergency physician members, and the more than 150 million Americans they treat each year. Through continuing education, research, public education and advocacy, ACEP promotes the highest quality of emergency care and is the leading advocate for emergency physicians, their patients and the public. As ACEP’s fourth executive director—and first female in this position—in the College’s more than 50-year history, Ms. Sedory’s thoughtful and incisive leadership style is guiding the organization through and beyond the current COVID-19 crisis to a newly defined era of emergency medicine.
Ms. Sedory has been the Executive Director of the Society of Interventional Radiology since 2011, leading the association of more than 8,100 interventional radiology physicians, scientists and clinical professionals in the shared goal to optimize minimally invasive patient care. Ms. Sedory also spent 10 years at the American Academy of Otolaryngology in various positions, including Chief Strategy Officer, and started her career as a researcher at the National Institute on Deafness and Other Communication Disorders at the National Institutes of Health and a health services researcher with The MEDSTAT Group.
Ms. Sedory holds a Master's Degree in Speech Science from the University of Maryland, and has authored numerous peer-reviewed papers. She received her Certified Association Executive (CAE) designation in 2008 and serves on the Advisory Board for Digital Now, the leading conference where association leaders tackle transformative and strategic issues.
Sue lives in Grapevine, TX, yet remains a die-hard Pittsburgh Steelers fan. She and her husband enjoy travel and just about any kind of indoor or outdoor fitness activities, especially if it involves their four grown children and their families.
Patricia Turner, MD, MBA, FACS
Patricia L. Turner, MD, MBA, FACS is the executive director and chief executive officer of the American College of Surgeons and a clinical professor at the University of Chicago Medicine. She was previously director of the Division of Member Services at the American College of Surgeons, and before joining the College, Dr. Turner spent eight years in full-time academic practice on the University of Maryland School of Medicine faculty, where she was the surgery residency program director. Roles in national professional organizations or institutions include member of the Boards of Directors of the Council of Medical Specialty Societies and OceanFirst Bank (OCFC), Corporate Member CEO of The Joint Commission, Specialty Society CEO Coalition member, 2024 president-elect of the Council of Medical Specialty Societies, and past chair of the Society of Black Academic Surgeons Foundation Fund, the American College of Surgeons’ Delegation to the AMA House of Delegates, AMA Council on Medical Education, and Surgical Section of the NMA, past president of the Society of Black Academic Surgeons and past member of the Wake Forest Baptist Medical Center Board of Directors.
A graduate of the University of Pennsylvania and the Bowman Gray School of Medicine at Wake Forest University, Dr. Turner continued her training as an intern and resident in surgery at Howard University Hospital in Washington, DC. Her fellowship training in minimally invasive and laparoscopic surgery was completed at the Mount Sinai School of Medicine, Weill-Cornell University School of Medicine, and Columbia University School of Medicine in New York City. Her MBA was completed at the University of Maryland Robert H. Smith School of Business. Dr. Turner is board-certified in surgery, is a Fellow of the American College of Surgeons, and is a member of the American Surgical Association, American Medical Association, National Medical Association, Southern Surgical Association, Southeastern Surgical Congress, Society of University Surgeons, Society of Black Academic Surgeons, Association of Women Surgeons, Latino Surgical Society, and an honorary member of EAST, the Excelsior Surgical Society, and Asociación Colombiana de Cirugia.
Michael Sheppard, CPA, CAE
Mike Sheppard is a business professional with over 25 years of corporate leadership experience. As the Chief Executive Officer of the AUA, he is responsible for AUA's four corporate entities, including the Urology Care Foundation, AUA’s official foundation for urologic patient education and research. In over 23 years with the AUA, Mr. Sheppard has held several executive level positions and has served as AUA's CEO since 2005.
Prior to joining the AUA, Mr. Sheppard served in senior level business positions at USF&G Realty Advisors, Inc., as a real estate portfolio controller, and C.W. Amos and Company, LLC as a senior independent public auditor. In addition, he is a retiree of the U.S. Naval Reserves Service. He has numerous professional affiliations, including memberships with the American Society of Association Executives, the American Institute of Certified Public Accountants, Greater Washington Society of Association Executives and Institute of Management Accountants Association. Mr. Sheppard received his MBA from Loyola College's Sellinger School. He is a Certified Public Accountant and Certified Association Executive. Mr. Sheppard is the recipient of several awards, including many military honors. He has written a number of published articles and participates on several committees for medical-related organizations, including a past Treasurer and Board member of the Council of Medical Specialty Societies.
Clifford Hudis, MD, FASCP, FASCO
Clifford Hudis, MD, FASCP, FASCO, is the CEO of the American Society of Clinical Oncology (ASCO) and serves as Executive Vice Chair of its foundation (Conquer Cancer) and Chair of the Board of its data enterprise (CancerLinQ). As CEO he oversees a staff of more than 500 who serve a global membership of more than 45,000 investigators and clinicians as they seek to reduce the burden of cancer through research, education, and the delivery of the highest quality care possible. ASCO holds the largest global meeting focused on cancer research, publishes the high impact Journal of Clinical Oncology, defines optimal quality of care, and advocates for access to it. ASCO’s foundation, Conquer Cancer is the largest funder of early career cancer researchers through its Young Investigator Award (YIA) and other programs. ASCO’s CancerLinQ is a physician-led non-profit big data enterprise that uses information from millions of patients to improve quality of care and inform faster development of new treatments.
Prior to assuming his roles at ASCO in 2016, Dr. Hudis was the Chief of the Breast Cancer Medicine Service, Solid Tumor Division, and an Attending Physician at the Memorial Hospital for Cancer and Allied Diseases, New York, New York and a Professor of Medicine at the Joan & Sanford Weill Medical College of Cornell University Medical College. Over nearly three decades, his team identified novel risk factors for cancer linked to inflammation and obesity and developed new drugs (G-CSF, taxanes, anti-HER2 agents) and regimens that raised the global standard of care across all stages of breast cancer.
In 1983 Dr. Hudis received his medical degree from The Medical College of Pennsylvania in Philadelphia, Pennsylvania through a 6-year combined BA-MD program with Lehigh University. He completed his internship and residency in Internal Medicine at The Hospital of the Medical College of Pennsylvania where he then served as Chief Medical Resident. He completed a fellowship in medical oncology and hematology at Memorial Sloan-Kettering Cancer Center in New York in 1991 and then joined the faculty where he continues to volunteer as a clinical consultant.
Kenneth Slaw, PhD
Dr. Slaw received his masters and doctoral degrees in educational psychology from the University of Illinois, Urbana-Champaign.
Ken has over 35 years of executive leadership experience in the medical society arena. He currently serves as the Executive Director, of the Society for Vascular Surgery, an organization of 6,500 members dedicated to the prevention and treatment of vascular disease. Prior to this he served on the Executive Staff of the American Academy of Pediatrics, an organization of 67,000 members dedicated to optimizing the health and well-being of children.
In his various roles Ken has developed and led implementation of 200+ organizational visioning and strategic plans, including the Vision of Pediatrics 2020 project. He also has a strong passion for leadership development. Ken served on the Steering Committee of the AAP Pediatric Leadership Alliance from its inception, and has been a principal curriculum architect, and lead faculty for Leadership programs reaching over 3,000 thousand physicians and allied health professionals with the message and skills to lead.
Ken has an impressive history of volunteer service and leadership in his profession as well as his community including:
- President of the American Association of Medical Society Executives(AAMSE)
- Founder, AAMSE Leadership Academy
- Finance Committee Member, Council on Medical Specialty Societies
- Founder and past Chairman, Membership Directors Consortium of the Council on Medical Specialty Societies (CMSS)
- Chairman of the Board, of the Make a Wish Foundation of Illinois
- Chairman, National Chapter Leadership Council of Make a Wish of America
- President, FD NOW, a national foundation Ken created with his spouse, Ann, to find treatment and cure for their son’s illness, familial dysautonomia
- Dr. Slaw is the recipient of 2013 University of Illinois Humanitarian Award
- Dr. Slaw is the recipient of the 2015 University of Illinois-College of Education Distinguished Educator Award
AT LARGE MEMBER
Mark Del Monte, JD
Mark Del Monte, JD serves as the CEO/Executive Vice President of the American Academy of Pediatrics (AAP). In this capacity, Mark leads a strong chief executive team for the organization which serves 67,000 pediatrician, pediatric medical subspecialist, and pediatric surgical specialist members. Prior to this role, Mark served as the AAP’s Chief Deputy and Senior Vice President for Advocacy and External Affairs where he directed the organization’s communications, public relations and advocacy activities.
Prior to joining AAP in 2005, Mark served as Director of Policy and Government Affairs for the AIDS Alliance for Children, Youth & Families, a national organization advocating for children and families with HIV/AIDS. Before moving to Washington, DC, Mark worked as a lawyer in his home state of California, providing direct legal services to HIV-positive, low-income children and families.
Mark holds a law degree from the University of California (Berkeley) and a bachelor’s degree from Gonzaga University.
AT LARGE MEMBER
Saul Levin, MD, MPA, FRCP-E, FRCPsych
Saul Levin, M.D., M.P.A., FRCP-E, FRCPsych, is the Chief Executive Officer and Medical Director of the American Psychiatric Association (APA). Prior to assuming this role in October 2013, Dr. Levin led the District of Columbia Department of Health (DOH). There, Dr. Levin was responsible for the health of the nation’s capital, including primary care for from infants to the seniors on Medicaid and Medicare, DC-funded health care, HIV/AIDS, addictions, health professional licensing and regulation, policy and planning. He was also responsible for health emergency preparedness, planning and coordinating alongside dozens of federal and local agencies to ensure the public’s health during major events such as President Obama’s second inauguration. Moreover, he promoted the development of a citywide health information exchange that connects health care providers, shares critical information to promote patient care, tracks outcomes, prepares for disasters and provides for public health surveillance.
Dr. Levin also served on the D.C. Health Exchange Board and chaired the Essential Health Benefits Package Subcommittee, where he successfully led the effort to ensure that residents of the District of Columbia had access to a full range of substance abuse and mental health services. He also co-chaired the committee that oversaw the integration of substance abuse and mental health services into the new Department of Behavioral Health.
In 2012, Dr. Levin served briefly as Senior Deputy Director of DOH’s Addiction Prevention and Recovery Administration. During his tenure, Dr. Levin promoted substance abuse prevention efforts in all eight wards of the city through the work of the Prevention and Access to Recovery teams, including implementation of over $20 million in federal grants for services, assessed and referred an increasing number of individuals into treatment services, and connected more clients to recovery support services.
Dr. Levin has long been involved in organized medicine and psychiatry. He served as Vice President for Science, Medicine, and Public Health at the American Medical Association. There, he oversaw programs related to evolving health delivery systems, such as in the areas of prevention and health care disparities. He also led efforts to improve the interface between clinical medicine and public health.
Among other positions Dr. Levin has held includes serving as a special expert appointee in the Substance Abuse and Mental Health Services Administration (SAMHSA), a division of the U.S. Department of Health and Human Services, where he led the initiative to integrate primary care, substance abuse, mental health, and HIV/AIDS response. While serving as President for Access Consulting International Inc., he worked with federal, state, and local governments and private companies to provide health policy, program, and research and evaluation services.
He is a former President and CEO of Medical Education for South African Blacks, an anti-apartheid education trust that provided scholarships to South African black students in health care. He helped award more than 11,000 scholarships to students studying to become physicians, nurses, substance abuse counselors and other health care professionals.
In 1982, Dr. Levin received his M.B.B.Ch. (M.D.) from the University Witwatersrand in Johannesburg, South Africa, and completed his residency in psychiatry at the University of California, Davis, Medical Center. In 1994, he received his master’s degree in public administration from Harvard University’s Kennedy School of Government. He is a Fellow of the Royal College of Physicians – Edinburgh, and Clinical Professor at George Washington University School of Medicine and Health Sciences in Washington, D.C.
AT LARGE MEMBER
Stephen McLeod, MD
Dr. McLeod is Chief Executive Officer for the American Academy of Ophthalmology and Professor and Chair Emeritus in the Department of Ophthalmology at the University of California, San Francisco. He pursued his undergraduate degree at Dartmouth College, followed by his medical doctorate degree at the Johns Hopkins University School of Medicine. He completed ophthalmology residency at the Illinois Eye and Ear Infirmary of the University of Illinois in Chicago, followed by fellowship training in cornea, external disease and refractive surgery at the Doheny Eye Institute.
Dr. McLeod’s clinical specialty is in refractive surgery, cornea and external disease. His research interests include the study of improved strategies for diagnosis and management of eye infections both in the U.S. and in the developing world, as well as the development of advanced cataract and refractive surgery technology.
Dr. McLeod is former Chair of the Ophthalmic Devices Panel of the Medical Devices Advisory Committee of the Food and Drug Administration. He has served as a member of the National Advisory Eye Council of the National Institutes of Health, on the Council of the American Ophthalmological Society, and on the Board of Directors of the American Board of Ophthalmology and the Heed Ophthalmic Foundation. He currently serves on the Board of Trustees for Research to Prevent Blindness. Dr. McLeod is former Editor-in-Chief for the AAO’s flagship peer review journal Ophthalmology.
AT LARGE MEMBER
Tracy Sereiko, MBA, CAE
Tracy Sereiko, MBA, CAE is a medical association executive with a passion for guiding transformation and innovation in mission-driven organizations amidst dynamic healthcare changes. She leads multidisciplinary teams to deliver results with emphasis on understanding member needs and driving member value. Her 20+ year career extends across strategic planning, governance facilitation, market and brand strategy, membership engagement strategy, educational product development, and technology strategy. Tracy is currently the Associate Executive Director, Specialty Engagement and Market Development at the American Academy of Physical Medicine and Rehabilitation (AAPM&R). Tracy has previously held senior leadership roles at SmithBucklin and worked with other non-profits. Tracy has an MBA from Kellogg School of Management at Northwestern University and a BA, Political Science with Honors and International Studies from Northwestern University.
PUBLIC BOARD MEMBER
Donna Cryer, JD
Donna R. Cryer, JD is Founder, President and Chief Executive Officer of Global Liver Institute, the only patient-driven liver health nonprofit operating across the US, EU, and UK. GLI convenes the NASH, Liver Cancer and Pediatric and Rare Liver Disease Councils, as well as the Liver Action Network, collectively more than 200 organizations.
Mrs. Cryer has channeled her personal experience as a patient with inflammatory bowel disease and a 27-year liver transplant recipient into professional advocacy across a career in law, policy, consulting, public relations, clinical trial recruitment, and nonprofit management. She is the recipient of the 2021 Global Genes RARE Champions of Hope Founder’s Award and the 2021 AASLD Distinguished Advocacy Service Award.
At GLI, Mrs. Cryer has raised more than $10 million for liver health initiatives. Among her many accomplishments with GLI, she developed a program featured by the White House on Solving Organ Shortage/Transplantation. She has launched numerous other successful programs at GLI, including the Cure Campaign, Advanced Advocacy Academy (A3), Liver Matters Blog, Liver Matters Health Policy Memo, the NASH Council, the Liver Cancers Council and the Pediatric and Rare Liver Diseases Council.
She is a frequent speaker on the topic of patient-centeredness and patient engagement in healthcare transformation and created a unique model for advocacy that mobilizes patients, influences policy, and coalesces clinicians to improve patient outcomes. In May 2021, she testified before the U.S. House Committee on Oversight and Reform, Subcommittee on Economic and Consumer Policy, in a pivotal hearing on reforming the broken organ procurement system. Her testimony highlighted the racial disparities in organ transplantation. Thanks to consistent, fact-based advocacy from GLI, other allied groups, the media, and Congress, meaningful reforms to improve the system are finalized and forthcoming. Her advocacy for better representation of people of color in the organ procurement system includes urging the U.S. Office of Management and Budget to implement three concrete steps she identified to facilitate more transplants for people of color and an elevated performance for the entire system, benefiting all patients.
For almost a decade, Mrs. Cryer founded and led CryerHealth, a healthcare consulting firm providing strategic counsel to top biopharmaceutical companies, patient advocacy organizations and emerging technology firms on patient engagement in health information technology, drug discovery and clinical decision making.
Earlier in her career, Mrs. Cryer worked at the United Network for Organ Sharing in Richmond, Va., where she negotiated organ allocation regulations with the Department of Health and Human Services as part of the special executive staff/board member team. She also organized an immunosuppressive coalition of pharmaceutical companies, transplantation groups and key congressional offices, resulting in increased coverage of immunosuppressive medications under Medicare.
Mrs. Cryer serves on the Boards of Directors for the Council of Medical Specialty Societies, Sibley Memorial Hospital/Johns Hopkins Medicine, the Innovation and Value Initiative (IVI), and the Clinical Trials Transformation Initiative. She was the first patient to serve on the ABIM Gastroenterology Specialty Board, was one of the founding members of the AASLD Patient Advisory Committee and is the Community Representative on the AASLD NASH Task Force. Previously, Mrs. Cryer served on the Executive Committee of the People-Centered Research Foundation. She was appointed by the U.S. Government Accountability Office to serve as the patient and consumer representative on the Health Information Technology Policy Committee, the federal advisory body to the National Coordinator for HIT. In addition, she served as a patient representative to the U.S. Food and Drug Administration, as a member of the Stakeholder Advisory Group to the NIH Learning Health System Research Collaboratory, as well as on the ABIM Gastroenterology Specialty Board and on an American Society of Clinical Oncology Guidelines Committee.
Mrs. Cryer was proud to serve as a member of the White House Task Force on e-health Equity in 2013. As part of the task force, she worked with a summit of experts on health disparities and health information technology to establish a framework to ensure that underserved populations benefit from advances in health technologies.
She has been named one of the Top Blacks in Healthcare by the Milken Institute at GW School of Public Health and BlackDoctors.org, one of the Top 10 Patients Who Make An Impact by Health 2.0 and one of PharmaVoice’s 100 Most Inspiring People. She is a frequent speaker on patient centricity in research and healthcare delivery at meetings of Biotechnology Innovation Organization (BIO), Pharmaceutical Research and Manufacturers of America (PhRMA), America's Health Insurance Plans (AHIP), National Quality Forum (NQF), American Association for Cancer Research (AACR), National Comprehensive Cancer Network® (NCCN®) and the National Academy of Medicine (NAM).
Mrs. Cryer received an undergraduate degree from Harvard and a Juris Doctorate from the Georgetown University Law Center.
CHIEF EXECUTIVE OFFICER (ex-officio Board Member)
Helen Burstin, MD, MPH, MACP
Helen Burstin, MD, MPH, MACP is the Chief Executive Officer of the Council of Medical Specialty Societies (CMSS), a coalition of more than 50 specialty societies representing more than 800,000 physicians. As the national organization of specialty societies, CMSS advances the expertise and collective voice of medical specialty societies in support of physicians and the patients they serve. Representing every specialty, from primary care to surgery, CMSS addresses critical issues across specialties through shared learning and innovation, convening, collaboration, and collective action.
Dr. Burstin formerly served as Chief Scientific Officer of The National Quality Forum (NQF). Prior to joining NQF, she was the Director of the Center for Primary Care, Prevention, and Clinical Partnerships at the Agency for Healthcare Research and Quality (AHRQ). Prior to joining AHRQ, Dr. Burstin was an Assistant Professor at Harvard Medical School and served as Director of Quality Measurement at Brigham and Women’s Hospital. She is the author of more than 100 articles and book chapters on quality, safety, equity, and measurement. She is a member of the National Academy of Medicine. Dr. Burstin currently serves on the board of the Society to Improve Diagnosis in Medicine. A graduate of the State University of New York at Upstate College of Medicine and the Harvard School of Public Health, Dr. Burstin completed her residency training in primary care internal medicine at Boston City Hospital and fellowship in General Internal Medicine and Health Services Research at Brigham and Women's Hospital and Harvard Medical School. She is a Clinical Professor of Medicine at George Washington University School of Medicine and Health Sciences.
CMSS Leadership Throughout the Years
Past CMSS Executive Vice President & CEOs:
-Richard S. Wilbur, MD, JD – 1976-1992
-Rebecca Rhine Gschwend, MA, MBA – 1992-2002
-Bruce E. Spivey, MD – 2002-2005
-Walter McDonald, MD, MACP – 2005-2007
-Norman Kahn, MD – 2008-2017